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ABSTRACT 
 
Air pollution exposure is a major problem worldwide and has been linked to 
many diseases. PM10 is one of the components of air pollution and it includes a 
mixture of compounds.  
Several studies suggest that PM produces significant effects on the 
cardiovascular system, in relation to acute as well as chronic exposure. 
This process has been extensively studied, but to date it has not yet been fully 
understood. Ambient particles have been shown to produce a strong 
inflammatory reaction, and beside pro-inflammatory mediators, cell-derived 
membrane Extracellular Vesicles (EVs) are also released. EVs (particularly 
microvesicles) might be the ideal candidate to mediate the effects of air 
pollution, since potentially they could transfer miRNAs, after internalization 
within target cells through surface-expressed ligands, enabling intercellular 
communication in the body.  
Our hypothesis is that, after air pollution exposure, the respiratory system can 
release extracellular vesicles that could reach the systemic circulation and 
lead to the development of endothelial disfunction. 
The aim of the study is to determine whether exposure to air particles and PM-
associated metals can modify EVs in plasma in term of: 
 miRNAs content 
  Quantity of MVs subpopulations 
Our study population represents a subgroup of the SPHERE projects that 
includes patients enrolled from Center for Obesity and Weight Control of the 
Department of Environmental and Occupational Health, University of Milan 
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and IRCCS Fondazione Ca’Granda – Ospedale Maggiore Policlinico. In 
particular we recruited 883 overweight/obese subjects for miRNAs study 
(recruited from 2010 till 2012) and 266 (recruited from January till November 
2013) subjects for MVs characterization. We chose overweight/obese people 
because some evidence shows that obesity may bring greater susceptibility to 
the adverse cardiovascular effects of PM exposure. 
Exposure is defined using a multifaceted approach. In particular, PM10 is 
assigned to each subjects following two approaches: (1) use of daily PM10 
concentration series from air quality monitors; (2) use of daily PM10 
concentration estimates  by the FARM model (the flexible air quality regional 
model) supplied by ARPA Lombardy.  
In the first part of the study, we analyzed the variation, in term of 
concentration, of plasma EVs in association with PM10 exposure. In particular 
we decided to investigate 5 subpopulations of microvesicles (MVs) by flow 
cytometry (MACS Quant Analyzers-Miltenyi Biotech): MVs from monocytes 
(CD14+), MVs from platelets (CD61+), MVs from neutrophils (CD66+), MVs 
from endothelium (CD105+), MVs from epithelium (EpCAM+).   
The second phase of the study represents a discovery stage that involves a 
miRNAs expression profiling using the OpenArray technology (QuantStudioTM 
12K FlexOpenArray-Life Technologies).  
The results of MVs subpopulation analysis in association with PM10 exposure 
show an increase of 6.6% in the concentration of MVs CD61+ (from platelets); 
3.4% for MVs CD66+ (neutrophils); 3.9% MVs for CD105+ (endothelium); 7% 
for MVs CD14+ (monocytes); while there is no significant association for MVs 
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EpCAM+ (from pulmonary epithelium). These results indicate the percentage 
increase of MVs concentration with an increase of 1μg / m3 of PM10. The total 
concentration of extracellular vesicles was analyzed by Nanoparticle Tracking 
Analysis (NTA), allowing to separate microvesicles from exosomes. The total 
amount of microvesicles is associated with PM10 exposure, while the total 
amount of exosomes is not significant. 
From miRNAs analysis, performed through TaqMan Open Array Real Time 
PCR, we test the association between PM10 exposure and the different levels 
of expression of 733 human miRNAs. 
This phase of the SPHERE study has the aim of screening the entire 
miRNome on a population of 833 subjects. From the results of this analysis 
have emerged 52 miRNAs as strongly associated with PM10 exposure. We 
performed a Mediation Analysis to investigate the potential role of the top 10 
miRNAs as mediators of the effect of PM10 exposure on cardiac outcomes, as 
Systolic Blood Pressure and Diastolic Blood Pressure. We can estimate that 
36.8% of the effect of PM10 on Systolic Blood Pressure is mediated by miR-
106a. Interestingly miR-106a seems to play a crucial regulatory role in regulate 
macrophage inflammatory responses, and is well known that macrophage 
infiltration  is involved in the processes of formation of atherosclerotic plaques. 
 The identified expression profile may provide a useful starting point for the 
understanding of the key mechanism that links PM10 exposure to the onset of 
cardiovascular diseases. 
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INTRODUCTION 
 
 
AIR POLLUTION 
 
Air pollution exposure is a major problem worldwide and has been linked to 
many diseases. 
Air pollution consists of gas and particle contaminants that are present in the 
atmosphere. Gaseous pollutants include SO2 , NOx , ozone, carbon monoxide 
(CO), volatile organic compounds (VOCs), certain toxic air pollutants, and 
some gaseous forms of metals. Particle pollution (PM2.5 and PM10) includes a 
mixture of compounds. The majority of these compounds can be grouped into 
five categories: sulfate, nitrate, elemental (black) carbon, organic carbon, and 
crustal material (Table 1). 
Some pollutants are released directly into the atmosphere. These include 
gases, such as SO2, and some particles, such as crustal material and 
elemental carbon. Other pollutants are formed in the air. 
Ground-level ozone forms when emissions of NOx and VOCs react in the 
presence of sunlight. Similarly, some particles are formed from other directly 
emitted pollutants. For example, particle sulfates result from SO2 and 
ammonia (NH3) gases reacting in the atmosphere. Commonly, emissions 
come from large stationary fuel combustion sources (such as electric utilities 
and industrial boilers), industrial and other processes (such as metal smelters, 
petroleum refineries, cement kilns, manufacturing facilities, and solvent 
utilization), and mobile sources including highway vehicles and non-road 
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sources (such as recreational and construction equipment, marine vessels, 
aircraft, and locomotives). 
Sources emit different combinations of pollutants. For example, electric utilities 
release SO2 , NOx , and Particles Fossil fuel combustion is the primary source 
contributing to CO2 emissions. Major sources of fossil fuel combustion include 
electricity generation, transportation (including personal and heavy-duty 
vehicles), industrial processes, residential, and commercial.[1] 
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Health, Environmental, and Climate Effects of Air Pollution 
Pollutant Health Effects Environmental and Climate Effects 
Ozone (O3) 
Decreases lung function and causes 
respiratory symptoms, such as 
coughing and shortness of breath; 
aggravates asthma and other lung 
diseases leading to increased 
medication use, hospital admissions, 
emergency department (ED) visits, and 
premature mortality. 
Damages vegetation by visibly injuring leaves, 
reducing photosynthesis, impairing reproduction and 
growth, and decreasing crop yields. Ozone damage to 
plants may alter ecosystem structure, reduce 
biodiversity, and decrease plant uptake of CO2. Ozone 
is also a greenhouse gas that contributes to the 
warming of the atmosphere. 
Particulate 
Matter (PM) 
Short-term exposures can aggravate 
heart or lung diseases leading to 
symptoms, increased medication use, 
hospital admissions, ED visits, and 
premature mortality; long-term 
exposures can lead to the development 
of heart or lung disease and premature 
mortality. 
Impairs visibility, adversely affects ecosystem 
processes, and damages and/or soils structures and 
property. Variable climate impacts depending on 
particle type. Most particles are reflective and lead to 
net cooling, while some (especially black carbon) 
absorb energy and lead to warming. Other impacts 
include changing the timing and location of traditional 
rainfall patterns. 
Lead (Pb) 
Damages the developing nervous 
system, resulting in IQ loss and impacts 
on learning, memory, and behavior in 
children. Cardiovascular and renal 
effects in adults and early effects 
related to anemia. 
Harms plants and wildlife, accumulates in soils, and 
adversely impacts both terrestrial and aquatic 
systems. 
Oxides of 
Sulfur (SOx) 
Aggravate asthma, leading to 
wheezing, chest tightness and 
shortness of breath, increased 
medication use, hospital admissions, 
and ED visits; very high levels can 
cause respiratory symptoms in people 
without lung disease. 
Contributes to the acidification of soil and surface 
water and mercury methylation in wetland areas. 
Causes injury to vegetation and local species losses 
in aquatic and terrestrial systems. Contributes to 
particle formation with associated environmental 
effects. Sulfate particles contribute to the cooling of 
the atmosphere. 
10 
 
 
 
Oxides of 
Nitrogen 
(NOx) 
Aggravate lung diseases leading to 
respiratory symptoms, hospital 
admissions, and ED visits; increase 
susceptibility to respiratory infection. 
Contributes to the acidification and nutrient 
enrichment (eutrophication, nitrogen saturation) of soil 
and surface water. 
Leads to biodiversity losses. Impacts levels of ozone, 
particles, and methane with associated environmental 
and climate effects. 
Carbon 
Monoxide 
(CO) 
Reduces the amount of oxygen 
reaching the body’s organs and tissues; 
aggravates heart disease, resulting in 
chest pain and other symptoms leading 
to hospital admissions and ED visits. 
Contributes to the formation of CO2 and ozone, 
greenhouse gases that warm the atmosphere. 
Ammonia 
(NH3) 
Contributes to particle formation with 
associated health effects. 
Contributes to eutrophication of surface water and 
nitrate contamination of ground water. Contributes to 
the formation of nitrate and sulfate particles with 
associated environmental and climate effects. 
Volatile 
Organic 
Compounds 
(VOCs) 
Some are toxic air pollutants that cause 
cancer and other serious health 
problems. Contribute to ozone 
formation with associated health 
effects. 
Contributes to ozone formation with associated 
environmental and climate effects. Contributes to the 
formation of CO2 and ozone, greenhouse gases that 
warm the atmosphere. 
Mercury (Hg) 
Causes liver, kidney, and brain damage 
and neurological and developmental 
damage. 
Deposits into rivers, lakes, and oceans where it 
accumulates in fish, resulting in exposure to humans 
and wildlife. 
Other Toxic 
Air Pollutants 
Cause cancer; immune system 
damage; and neurological, 
reproductive, developmental, 
respiratory, and other health problems. 
Some toxic air pollutants contribute to 
ozone and particle pollution with 
associated health effects. 
Harmful to wildlife and livestock. Some toxic air 
pollutants accumulate in the food chain. Some toxic 
air pollutants contribute to ozone and particle pollution 
with associated environmental and climate effects. 
Table 1. Health, Environmental, and Climate Effects of Air Pollution Components. U.S 
Environmental Protection Agency's Report 2010 
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PARTICULATE MATTER 
 
PM is a mixture of suspended particles that vary in chemical composition and 
size. 
Particulate matter varies in number, size, shape, surface area, chemical 
composition and characteristics, and can be of both natural and 
anthropological origin. 
The size distribution of urban ambient particle pollution is usually 
characterized by aerodynamic diameter (AED) which is defined as the 
diameter of a sphere of unit density (lg/cm3) that has the same inertial  
properties in the gas as the particle of interest. 
The size distribution of suspended particles in the atmosphere is tri-modal and 
includes coarse particles, line particles, and ultrafine particles. 
Coarse particles (PM2,5-10: often defined as those with an aerodynamic 
diameter > 2.5µm) are primarily produced by natural mechanisms such as 
grinding and  wind, and derive mainly from soil and other crustal materials. 
Fine particles (PM2.5: diameter < 2.5 µm ) are derived chiefly from combustion  
processes. In the urban environment these process are associated with  
transportation, manufacturing, and power generation. Ultrafine particles are 
often defined as particles less than or equal to 0,1 µm. (Figure 1) 
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Particles can either be directly emitted into the air (primary PM) or be formed 
in the  atmosphere from gaseous precursors such as sulfur dioxide, oxides of 
nitrogen, ammonia  and non-methane volatile organic compounds (secondary 
particles). 
Primary PM and the precursor gases can have both man-made 
(anthropogenic) and natural (non-anthropogenic) sources. Anthropogenic 
sources include combustion engines (both diesel and petrol), solid-fuel  (coal, 
lignite, heavy oil and biomass) combustion for energy production in 
households and  industry, other industrial activities (building, mining, 
manufacture of cement, ceramic and  bricks, and smelting), and erosion of the 
pavement by road traffic and abrasion of brakes and tyres.  
Agriculture is the main source of ammonium. 
Figure 1. Particle pollution size. U.S EPA 
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Secondary particles are formed in the air through chemical reactions of 
gaseous pollutants.  
They are products of atmospheric transformation of nitrogen oxides (mainly 
emitted by traffic and some industrial processes) and sulfur dioxide resulting 
from the combustion of  sulfur-containing fuels. Secondary particles are mostly 
found in fine PM. 
Soil and dust re-suspension is also a contributing source of PM, particularly in 
arid areas or  during episodes of long-range transport of dust, for example 
from the Sahara to southern Europe.[2] 
PM10 and PM2.5 include inhalable particles that are small enough to penetrate 
the thoracic region of the respiratory system. The health effects of inhalable 
PM are well documented.  
They are due to exposure over both the short term (hours, days) and long term 
(months, years) and include: 
• respiratory and cardiovascular morbidity, such as aggravation of asthma, 
respiratory symptoms and an increase in hospital admissions; 
• mortality from cardiovascular and respiratory diseases and from lung cancer. 
There is good evidence of the effects of short-term exposure to PM10 on 
respiratory health, but for mortality, and especially as a consequence of long-
term exposure, PM2.5 is a stronger risk factor than the coarse part of PM10 
(particles in the 2.5–10 μm range). All-cause daily mortality is estimated to 
increase by 0.2–0.6% per 10 μg/m3 of PM10[3, 4]. Long-term exposure to 
PM2.5 is associated with an increase in the long-term risk of cardiopulmonary 
mortality by 6–13% per 10 μg/m3 of PM2.5 [5-7] 
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Susceptible groups with pre-existing lung or heart disease, as well as elderly 
people and children, are particularly vulnerable. For example, exposure to PM 
affects lung development in children, including reversible deficits in lung 
function as well as chronically reduced lung growth rate and a deficit in long-
term lung function [8]. There is no evidence of a safe level of exposure or a 
threshold below which no adverse health effects occur. The exposure is 
ubiquitous and involuntary, increasing the significance of this determinant of 
health. 
At present, at the population level, there is not enough evidence to identify 
differences in the effects of particles with different chemical compositions or 
emanating from various sources. It should be noted, however, that the 
evidence for the hazardous nature of combustion-related PM (from both 
mobile and stationary sources) is more consistent than that for PM from other 
sources [9]. The black carbon part of PM2.5, which results from incomplete 
combustion, has attracted the attention of the air quality community owing to 
the evidence for its contribution to detrimental effects on health as well as on 
climate. 
Many components of PM attached to black carbon are currently seen as 
responsible for health effects, for instance organics such as PAHs that are 
known carcinogens and directly toxic to the cells, as well as metals and 
inorganic salts. 
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PM AND CARDIOVASCULAR HEALTH EFFECTS 
 
Several studies suggest that PM produces significant effects on the 
cardiovascular system[10-12]. Research on this topic has focused on both the 
long-term effects of chronic PM exposure and the acute effects of increases in 
ambient PM on cardiovascular mortality.  
In a previous analysis[13], it was shown that for any increase in mortality 
caused by PM, two thirds of the effect was accounted for by the cardiovascular 
diseases. 
Animal studies show a link between chronic PM exposure and the 
development of atherosclerosis via systemic inflammation[14, 15]. Human 
studies show that the effects seem to be mediated by the inflammatory 
cytokines IL-6, TNF-α, and C reactive protein (CRP). Increases in both IL-6[16] 
and CRP[17] have been associated with the development of acute myocardial 
infarction. Ruckerl et al.[18] described transient IL-6 and TNF-α elevations in 
diabetic patients for 2 days following PM10 exposure. In a prospective cohort 
study of German patients, Hoffman et al.[19] associated exposure to PM2.5 
with elevations in CRP.  
Other researchers demonstrated similar increases in CRP from PM10 exposure  
from both combustion[20] and organic matter[21].  
Acute exposure to PM causes changes in coagulation and platelet activation 
providing a more proximal link between PM and coronary artery disease. Many 
experts consider fibrinogen to be an important risk factor for cardiovascular 
disease[13]. Ruckerl et al. [18] associated a 5-day cumulative exposure to 
PM10 with increased fibrinogen levels in survivors of myocardial infarction. 
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Other pro-coagulant factors, such as plasminogen activator fibrinogen 
inhibitor-1 (PAI-1), were also associated with PM elevations[21]. Intratracheal 
instillation of diesel exhaust particles led to increased platelet activation in 
hamsters and rapid thrombosis formation [22]. 
Schicker et al.[21] showed that transient increases in PM10 exposure caused 
during hay-stacking increased platelet aggregation within 2 h of the activity. 
This activity also increased VonWillebrand factor and Factor VIII, markers of 
vascular endothelial activation. 
The “Harvard Six Cities study,” [11] a cohort study published in 1993, followed 
8,111 patients for 16–18 years and showed a 29% (95% CI, 8–47%) increase 
in the adjusted mortality rate for the most polluted of the cities compared to the 
least polluted.  
Particulate air pollution was positively associated with death from lung cancer 
and cardiopulmonary disease. 
Pope et al. [10] followed this in 1995 with another prospective cohort study of 
552,000 patients in 151 metropolitan areas using the American Cancer 
Society's Cancer Prevention 2 database. These data showed a 17% (95% CI, 
9–26%) increase in all-cause mortality and a 31% (95% CI, 17–46%) increase 
in cardiopulmonary mortality when comparing the most and least polluted 
cities.  
Their research demonstrated an average increase in cardiopulmonary 
mortality of 9% (95% CI, 3–16%) for each 10-μg/m3 increase in PM2.5. 
Subsequently, they determined that a 10μg/m3 increase in PM increased 
ischemic cardiovascular disease mortality by 18% (95% CI, 14–23%) and 
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mortality from arrhythmia, congestive heart failure, and cardiac arrest by 13% 
(95% CI, 5–21%). 
 
 
EXTRACELLULAR VESICLES 
 
Intercellular communication is an essential hallmark of multicellular organisms 
and can be mediated through direct cell–cell contact or transfer of secreted 
molecules. In the last two decades, a third mechanism for intercellular 
communication has emerged that involves intercellular transfer of extracellular 
vesicles (EVs). The release of apoptotic bodies during apoptosis has been 
long known[23], but only recently the fact that also healthy cells shed vesicles 
from their plasma membrane become acknowledged. 
The term exosome was initially used for vesicles ranging from 40 to 1,000 nm 
that are released by a variety of cultured cells[24], but the subcellular origin of 
these vesicles was unclear. Later, this nomenclature was adopted for 40–100 
nm vesicles released during reticulocyte differentiation as a consequence of 
multivesicular endosome (MVE) fusion with the plasma membrane[25]. 
However, circulating vesicles are composed of both exosomes and 
microvesicles (MVs) (Figure 2). 
Microvesicles are larger than exosomes (100-1000 nm) and are released into 
the extracellular space by outward budding of the cell membrane. On the other 
hand, exosomes are produced by a more complex inward budding of 
endosomes[26].  
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1)  Exosomes 
Exosome is the vesicle type that has been studied most intensely.  
Exosomes are secreted by many cell types, and have been isolated from 
several physiological fluids such as sperm[27], urine[28], plasma[29], and 
bronchial lavage fluid[30]. Their diameter range from 40 to 100 nm, a 
homogeneous shape, with a density of 1.13-1.19 g/mL in sucrose, and can be 
sedimented at 100,000 g. 
They originate from inward budding of the limiting membrane of multivesicular 
bodies, which are late endosomal compartments present in the cytosol of the 
cell. When the multivesicular bodies fuse with the plasma membrane they 
release exosomes to the extracellular space.  
Figure 2. Extracellular vesicles. Meckes D G , and Raab-Traub N J. Virol. 
2011;85:12844-12854 
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The biogenesis of the exosomes causes the orientation of the membrane 
proteins to be similar to that of the plasma membrane.  
The exosomal membrane is enriched in cholesterol, ceramide, and 
sphingomyelin and exposes the phospholipid phos- phatidylserine. 
These makers are not ubiquitously expressed on all exosomes but are found 
in a large proportion of these vesicles. Therefore, they are generally accepted 
as exosomal markers. These markers include TSG101, Alix, and the 
tetraspanins CD9, CD63, and CD81.[31] 
They are formed from multivesicular bodies (MVBs), which are intracellular 
endosomal organelles, characterized by multiple intraluminal vesicles 
enclosed within a single outer membrane. MVBs are formed from early 
endosomes, which as prelysosomal structures belong to the degradative 
endosomal pathway of internalized proteins. They are now known to be 
involved in numerous endocytic and trafficking functions, including protein 
sorting, recycling, transport, storage, and release. 
There are two types of MVBs, one in the degradative pathway and another in 
the exocytosis or recycling pathway [32]. 
Early endosomes can interact with the Golgi apparatus and the endoplasmic 
reticulum. Exosomes can be formed by endocytosis of the early endosome 
membrane, having a unique orientation of the involuted cytoplasmic side[33, 
34]. Generation of MVBs as well as secretion of exosomes are mediated by 
endosomal complexes required for transport (ESCRT complexes). These 
protein complexes are involved in the recognition of ubiquitinated content by 
MVBs, as well as the invagination of the MVB outer membrane[35, 36]. 
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The origin of exosomes suggests that their production is stimulated in 
response to alterations in the microenvironment. 
The formation of early endosomes and MVBs has been shown to increase 
upon signaling via growth factor receptors, suggesting that the cell adjusts 
exosome production according to its need[28, 37]. 
               
2) Microvesicles 
Microvesicles are extracellular vesicles ranging in size from 100-1000 nm, with 
different shapes. Although some authors use the term microvesicles for 
extracellular vesicles in general, the main differences between exosomes and 
microvesicles depend on size, formation, and the secretion process. They are 
formed by regulated release of outward budding of the plasma membrane, 
consequently they also express antigenic markers of the cell from which they 
originate. 
Several authors use different markers for microvesicles like flotillin-2, 
selectins, integrins, metalloproteinases, and a high level of phosphatidylserine 
on the outer surface. There are some resemblances between microvesicles 
and exosomes: both carry proteins, mRNA, and microRNA (miRNA) and are 
involved in cellular communication[38, 39], possibly through the horizontal 
transfer of genetic material, directly stimulating the target cell by transferring 
receptors or proteins. 
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The generation of MVs is dependent on both the cell and the stimulus, with 
lipid bilayer rearrangement (or derangement) being a critical component of MV 
formation[40]. Main differences between extracellular vesicles are summarized 
in Table 2. 
 
 
 Characteristics 
Vesicle types Origin Size Markers Contents 
Exosomes 
Endolysosomal pathway; 
intra- luminal budding of 
multivesicular bodies and 
fusion of multivesicular body 
with cell membrane 
40–120 
nm 
Tetraspanins (such 
as TSPAN29 and 
TSPAN30), ESCRT 
components, 
PDCD6IP, TSG101, 
flotillin, MFGE8 
mRNA, microRNA 
(miRNA) and 
other non-coding 
RNAs; 
cytoplasmic and 
membrane 
proteins including 
receptors and 
major 
histocompatibility 
complex (MHC) 
molecules 
Microvesicles Cell surface; outward 
budding of cell membrane 
50–1,000 
nm 
Integrins, selectins, 
CD40 ligand 
mRNA, miRNA, 
non-coding RNAs, 
cytoplasmic 
proteins and 
membrane 
proteins, including 
receptors 
Apoptotic 
bodies 
Cell surface; outward 
blebbing of apoptotic cell 
membrane 
500–
2,000 nm 
Extensive amounts 
of 
phosphatidylserine 
Nuclear fractions, 
cell organelles 
 
 
 
 
 
Table 2. Main differences between extracellular vesicles 
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BIOGENESIS OF EXTRACELLULAR VESICLES 
 
Exosomes are presumed to be a homogeneous population of vesicles of 
endocytic origin that are formed by the inward budding of the multivesicular 
body (MVB) membrane. Cargo sorting into exosomes involves the endosomal 
sorting complex required for transport (ESCRT) and other associated proteins 
such as programmed cell death 6 interacting protein (PDCD6IP; also known 
as ALIX) and tumour susceptibility gene 101 protein (TSG101)[41-43]. In 
addition to ESCRT, which recognizes ubiquitylated proteins, other ESCRT-
independent mechanisms operate to generate exosomes of certain 
biochemical compositions. For example, in some cells, exosome production 
requires the lipid ceramide and neutral sphingomyelinase — the enzyme that 
converts sphingomyelin to ceramide. 
Exosomes are secreted following the fusion of MVBs with the cell membrane 
— a process that is, in some cells, dependent on small GTPases such as 
RAB27A, RAB11 and RAB31.  
An alternative mechanism for the secretion of WNT-bound exosomes was 
recently shown to involve the SNARE (soluble NSF (N-ethylmaleimide-
sensitive factor) attachment protein (SNAP) receptor) protein YKT6. 
Exosomes display the same membrane orientation as the cell of origin, 
similarly to microvesicles. Microvesicles, however, represent a relatively 
heterogeneous population of vesicles that are formed by the outward budding 
and fission of the cell membrane, which could be controlled by membrane lipid 
microdomains and regulatory proteins such as ADP-ribosylation factor 6 
(ARF6)[44]. Extracellular vesicles can be regarded as signalosomes for 
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several biological processes. They can be involved in antigen presentation 
and in the transfer of both major histocompatibility complex (MHC) molecules 
and antigens, thereby participating in immune regulation. Extracellular vesicles 
can directly activate cell surface receptors via protein and bioactive lipid 
ligands, transfer cell surface receptors or deliver effectors including 
transcription factors, oncogenes and infectious particles into recipient cells5. In 
addition, various RNA species including mRNAs and small regulatory RNAs 
(for example, microRNAs (miRNAs) and non-coding RNAs) are contained in 
extracellular vesicles and functionally delivered to recipient cells[45] (Figure 3). 
 
 
                          
Figure 3: EVs Biogenesis and interactions. Mager, I., Breakefield, 
X. O., & Wood, M. J. (2013) Nat Rev Drug Discov, 12(5), 347-357 
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miRNAs: BIOGENESIS, MECHANISMS OF ACTION AND ROLES 
 
MicroRNAs, also called miRNAs, are small 19 – 22 nucleotide (nt) sequences 
of noncoding RNA that work as endogenous epigenetic gene expression 
regulators. 
MicroRNAs are transcribed by RNA polymerase II and/or RNA polymerase III 
as long 100 – 1000 nt primary, or pri-miRNAs , which are usually capped at 
the 5´end and are polyadenylated at the 3´end. 
Pri-miRNAs are sequentially processed by the ribonucleases Drosha and 
Pasha (DGCR8) to produce 60–70 nt pre-miRNAs, which have a 5-phosphate 
and a 2 nt overhang at the 3´end. These products are then exported to the 
cytoplasm by Exportin-5 where they bind to the ribonuclease Dicer and are 
processed to yield a double-strand miRNA: miRNA. Finally, a helicase 
unwinds the duplex into mature miRNAs.[46] 
Mature miRNAs are incorporated to the RNA-induced silencing complex 
(RISC) and bind to the complementary 3´-UTR of their specific target mRNAs. 
This either results in inhibition of mRNA translation or promotes its 
degradation and leads to posttranscriptional gene silencing (PTGS).[47, 48] 
Additionally, the RNA-induced transcriptional silencing (RITS) complex, which 
uses AgoI instead of AgoII in its effector complex, was described almost a 
decade ago.[49] 
This complex exerts DNA/histone modifications (e.g., methylation) on the 
genome and therefore triggers transcriptional gene silencing. Although RITS 
has been identified in many species so far, it is yet to be confirmed in humans. 
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In most cases, the ‘‘ seed region’’ (the 7–8 bases after the first or second base 
of the 5´end of the miRNA) perfectly complements the corresponding target-
mRNA sequence. 
Nucleotide base pairing also occurs at the 3´region of the miRNA, although it 
is thought to be weaker and less important than the 5´pairing. Duplex 
mismatches between miRNA: miRNAs cause the formation of bulge structures 
in the central region, which may be useful for mRNA regulation (Figure.4). 
Because of the short recognition elements, the same miRNA can recognize 
hundreds of gene targets, , and at the same time, each gene can be targeted 
by several miRNAs. 
MicroRNAs are expressed in all tissues and regulate a wide spectrum of 
processes, such as cellular differentiation, proliferation, and apoptosis.[50] 
Moreover, the roles exerted by miRNAs can be very different from each other. 
For example, in cancer, several miRNAs have been thoroughly characterized 
and classified as oncogene regulators (oncomiRs); in contrast, others have 
been described as tumor suppressors, such as the let-7 family which can 
target oncogenes such as RAS, MYC, HMGA2, and cell cycle 
checkpoints[46]..  
These molecules are not only present in tissues but also in a variety of biologic 
samples (e.g., whole blood, serum, plasma, urine, and saliva). 
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Figure 4.MicroRNA biogenesis and mechanisms of action. Moreno-Moya, 
J. M., Vilella, F., & Simon, C. (2014) Fertil Steril, 101(6), 1516-1523. 
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BIOLOGICAL AND PATHOLOGICAL ROLES OF EXTRACELLULAR 
VESICLES 
 
It is now recognized that MVs are an integral part of the intercellular 
microenvironment and may act as regulators of cell-to-cell communication.  
This concept is based on the observation that MVs released from a given cell 
type may interact through specific receptor ligands with other cells, leading to 
target cell stimulation directly or by transferring surface receptors.[51, 52] 
This implicates that MVs interact only with target cells that specifically 
recognize rather than just with any cell present in the microenvironment.[53] 
This interaction may either be limited to a receptor-mediated binding to the 
surface of target cells forming a platform for assembly of multimolecular 
complexes or leading to cell signaling, either to be followed by internalization 
as a result of direct fusion or endocytic uptake by target cells. Once 
internalized, MVs can fuse their membranes with those of endosomes, thus 
leading to a horizontal transfer of their content in the cytosol of target cells.  
Extracellular vesicles exert their effects on fundamental biological directly 
activating cell surface receptors via protein and bioactive lipid ligands and 
delivering effectors including transcription factors, oncogenes, small and large 
non-coding regulatory RNAs (such as microRNAs (miRNAs)), mRNAs and 
infectious particles into recipient cells.[45, 54, 55]   Alternatively, they may 
remain segregated within endosomes and be transferred to lysosomes or 
dismissed by the cells following the fusion with the plasmamembrane, thus 
leading to a process of transcytosis[56]. 
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In this way, extracellular vesicles participate in the maintenance of normal 
physiology — for example, stem cell maintenance[57], tissue repair[58], 
immune surveillance[59] and blood coagulation[60]. Extracellular vesicles can 
thus be regarded as signalosomes: multifunctional signalling complexes for 
controlling fundamental cellular and biological functions.  
For example, in the regulation of immune responses, depending on the status 
of particular immune cells, extracellular vesicles might trigger adaptive 
immune responses or suppress inflammation in a tolerogenic manner. 
Extracellular vesicles have been shown to confer immune suppression by 
several mechanisms: they can enhance the function of regulatory T cells[61], 
suppress natural killer (NK) and CD8+ cell activity[62], and inhibit monocyte 
differentiation into DCs[63] as well as DC maturation. By contrast, the effects 
of immune activation can be mediated by extracellular vesicle-promoted 
proliferation and survival of haematopoietic stem cells and the activation of 
monocytes[64], B cells[65] and NK cells[66].  
In the brain, in addition to classical synaptic neurotransmission, neurons com-
municate via the secretion of extracellular vesicles that can contribute to a 
range of neurobiological functions (including synaptic plasticity) — for 
example, via the increased release of extracellular vesicles containing 
neurotransmitter receptors from cortical neurons following enhanced glu-
tamatergic activity[67]. Extracellular vesicles have also been implicated in cell 
phenotype modulation — for example, in converting the haematopoietic stem 
cell phenotype into a liver cell phenotype  and in shifting the bone marrow cell 
transcriptome and proteome towards a lung phenotype in vivo[68]. Importantly, 
29 
 
several reports have implicated extracellular vesicles in stem cell maintenance 
and plasticity, indicating that stem cell-derived extracellular vesicles have a 
pivotal role in tissue regeneration following injury[57].  
Such wide-ranging cellular and biological functions indicate that extracellular 
vesicles, by virtue of their pleiotropic signalling effects, may have innate 
therapeutic potential — for example, in the fields of regenerative medicine and 
immunotherapy. 
Given their fundamental role in regulating biological processes, it is not 
surprising that in some contexts extracellular vesicles have an important role 
in disease pathogenesis. The best understood role of extracellular vesicles in 
disease is their role in tumour biology: numerous studies have implicated 
extracellular vesicles in driving the formation of a pre-metastatic tumour 
niche[69]. Extracellular vesicles are capable of stimulating tumor 
progression[55, 69] via their ability to carry out the following processes: induc-
ing proliferation in cells, thereby directly stimulating tumor growth[39, 70]; 
stimulating angiogenesis[71]; promoting matrix remodelling via the secretion of 
matrix proteases[72]; inducing metastasis; and promoting immune escape by 
modulating T cell activity[73, 74]. 
Beyond cancer, extracellular vesicles have been implicated in the spread of 
numerous pathogens, including: HIV-1, via the horizontal transfer of CC 
chemokine receptor 5 (CCR5), which is used for viral cell entry[75]; Epstein–
Barr virus (EBV), via the transfer of viral miRNAs that repress the expression 
of EBV target genes in non-infected cells[76]; and prions, via the selective 
delivery of PrP with certain modifications and glycoforms into neuronal cells.  
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It is also likely that extracellular vesicles contribute to the local propagation of 
neurodegenerative disease. Neurons are known to communicate through the 
secretion of extracellular vesicles, which contribute to local synaptic plasticity, 
but these extracellular vesicles also allow longer-range communication within 
the central nervous system and have an influence on static neuronal networks 
located at a distance[77]. This has been elegantly demonstrated in the context 
of Alzheimer’s disease, in which amyloid-β peptides, the toxic protein species 
for this disease, have been shown to be released in association with 
exosomes, contributing to pathogenic amyloid-β deposition in other parts of 
the brain[78]. Similarly, α-synuclein protein has been detected within 
extracellular vesicles, which could provide a mechanism for the local 
propagation of Parkinson’s disease from enteric neurons to the brainstem and 
higher cortical centres[79]. Study into the pathological role of EV-mediated 
miRNA transfer, and their potential application as disease biomarkers or even 
therapeutic agents, is a field of interest and many potential targets have been 
identified (Table 3). 
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Disease EV source miRNA 
content Putative effect/target Reference 
Asthma  Bronchoalveolar 
lavage fluid 
let-7 and miR-200 
families 
Biomarkers of mild 
nonsymptomatic asthma  
 
Levanen et 
al.[80] 
Cardiovascular 
disease 
 
Injured/dying 
cardiomyocytes  
 
Urine  
 
 
 
Plasma of 
atherosclerosis 
patients 
 
miR-133a 
 
 
 miR-4516, miR-
3183, (miR-3940-
5p),(miR-4649-5p) 
 
miR-150 
Biomarker; regulation of cardiac 
hypertrophy  
 
Biomarkers of salt sensitivity or 
inverse salt sensitivity index 
 
 
Reduced c-Myb expression and 
increased cell migration in 
recipient microvascular 
endothelial cells 
 
Kuwabara et 
al. [81] 
 
Gildea et al. 
[82] 
 
 
Zhang et al. 
[83] 
Colorectal 
cancer  
 
Serum of colorectal 
cancer 
patients 
 
 
Plasma of mice with 
colorectal 
cancer xenografts 
 
let-7a, miR-1229, 
miR-1246, miR-
150,miR-21, miR-
223, and miR-23a 
 
miR-92a 
Biomarkers  
 
 
 
 
Enhanced proliferation and 
motility in recipient endothelial 
cells, down-regulation of target 
Dickkopf-3 tumor suppressive 
gene 
 
 
 
Ogata-Kawata 
et [84] 
 
 
Yamada et 
al.[85]  
Lung cancer  
 
Plasma from NSCLC 
patients  
 
Plasma from lung 
SCC patients  
(let-7f), (miR-20b), 
(miR-30e-3)  
 
miR-205, miR-19a, 
miR-19b,miR 
30b,miR-20a 
 
NSCLC diagnosis and prognosis  
 
 
SCC biomarkers; oncomiRs 
Silva et al. [86] 
 
 
Aushev et al. 
[87] 
Cancer 
(angiogenesis/ 
metastasis) 
 
Hypoxic K562 
leukaemia cell lines 
 
 
Brain metastatic 
cancer cell lines 
 
 
Metastatic rat 
adenocarcinoma 
miR-210  
 
 
 
miR-210, (miR-
19a), (miR-29c) 
 
  
miR-494, miR-542-
3p 
Induction of angiogenesis in 
recipient endothelial 
cells 
 
Biomarkers; potential prognostic 
agent for brain metastatic breast 
cancer and melanoma 
 
Downregulation of cadhedrin-17 
and concomitant up-regulation 
of matrix metalloproteinase 
transcription, preparation of a 
pre-metastatic niche 
 
Tadokoro et 
al.[88] 
 
 
Camacho et 
al.[89] 
 
 
Rana et al[90] 
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Stroke MSCs miR-133b Enhanced neurite remodelling; 
Increased functional recovery 
and neurovascular plasticity in 
rat stroke models 
 
Xin et al.[91] 
 
Atherosclerosis  
 
KLF2-transduced or 
shearstressed 
HUVECs 
 
miR-143/145 
cluster 
Regulation of smooth muscle 
cell function, reduced 
atherosclerotic lesion formation 
 
Hergenreider 
et al. [92] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. miRNAs identified in EVs as relevant to pathophysiological conditions or putative 
therapeutic applications. 
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SPECIFIC AIMS 
 
 
Although several studies have tried to identify the mechanism responsible for 
the link between PM and cardiovascular diseases, until now this process is not 
really understood. 
The main proposal of our research is to determine whether exposure to PM 
can modify extracellular vesicles, in particular MVs, in term of quantity, cellular 
origin and miRNAs content.  
Our hypothesis is that, after air pollution exposure, the respiratory system can 
release extracellular vesicles that could reach the systemic circulation and 
lead to the development of endothelial disfunctions (Figure 5). 
EVs, after internalization within target cells through surface-expressed ligands, 
may transfer miRNAs enabling intercellular communication in the body. 
According to this hypothesis our research will focus on: 
Determine whether exposure to air particles and PM-associated metals can 
modify EVs in plasma in term of: 
  miRNAs content 
  Quantity of MVs subpopulations 
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Figure 5. Proposed mechanism for air pollution effects on microvesicle release and  
cell-to-cell communication. 
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MATERIALS AND METHODS 
 
STUDY POPULATION 
 
The study population represents a subgroup of the SPHERE project 
(Susceptibility to Particle Health Effects, miRNAs and Exosomes). The 
SPHERE study is a cross-sectional study investigating the effects of 
particulate air pollution on a population of susceptible overweight/obese 
subjects, recruited in Lombardy Region, Italy. The population examined in this 
study includes 1250 subjects. The overall study enrollment target will be to 
recruit 2,000 participants. 
We recruited patients from Center for Obesity and Weight Control of the 
Department of Environmental and Occupational Health, University of Milan 
and IRCCS Fondazione Ca’Granda – Ospedale Maggiore Policlinico.  
We chose obese people because some evidence shows that obesity may 
bring greater susceptibility [93, 94] to the adverse cardiovascular effects of PM 
exposure. In addition, It has been shown that obese people are more 
susceptible to the effect of inflammation in the short-term exposure to PM, 
presenting higher levels of C-reactive protein and interleukin-6, compared with 
normal-weight subjects, at the same exposure of PM level [95]. 
The eligibility criteria for participants are as follows: 1) older than  18 years at 
enrollment;  2) obese/overweight according to the following definition: 
overweight is defined as a BMI between 25 and 30 kg/cm², obesity is defined 
as a BMI of 30 kg/cm² or more; 4) domiciled in Lombardy at the time of the 
recruitment; 5) agreement to sign an informed consent and donate a blood 
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sample. 
Exclusion criteria include:  experienced previously diagnosed cancer, heart 
disease or stroke in the last year or other chronic diseases such as multiple 
sclerosis, Alzheimer’s disease, Parkinson’s disease, depression, bipolar 
disorder, schizophrenia and epilepsy. 
As part of the routine protocol, for each subject presenting at the Center, 
extensive physical examination, spirometry, ECG are performed and 
biochemical tests are also collected, including  Emocrome, Fibrinogen, C-
reactive protein, Total cholesterol, HDL, LDL, Triglyceride, Serum creatinine, 
AST, ALT, Gamma-Glutamyltransferase, Glucose, Homocysteine, TSH, 
Glycated haemoglobin, Postprandial glycaemia, Insulin level, 2-hour post 
glucose insulin level, Urinary pH, Uric acid. 
For the specific purpose of the present project each subject will be asked to: 
-  Sign an informed consent form explaining the study aims and procedures. 
-  2 EDTA tubes blood samples ( ̴ 15 ml)  
- 1 PAXgene Blood RNA tube ( ̴ 2,5ml) 
- urine samples ( ̴ 50 ml) 
- hair sample (next to the root) 
Each subject was administered a questionnaire to collect information on the 
major cardiovascular risk factors, in particular a lifestyle questionnaire and a 
diet questionnaire. The lifestyle questionnaire collects information on socio-
demographic data, residential area (complete address, characteristics of the 
house, and traffic), education, past and present health status of the subjects 
and their first-degree relatives, medications in the last year, employment 
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history and for employed subjects address of the plant of their current work, 
smoking history, passive smoking at home and at workplace, physical activity 
levels and sedentary behavior, commuting time and transport mode. 
The  questionnaire on eating habits included questions on the number of 
servings from each food in a usual week or month. Several different types of 
food were investigated, including: legumes, vegetables, fruits, nuts, red and 
white meat, fish, eggs, dairy products, cereals, snacks, oil and butter, alcoholic 
beverage, tea and coffee. Number of servings from each food were translated 
into usual daily micronutrients intake weighting for serving size, age class and 
gender.  
Both questionnaires were checked for completeness at the time of data 
collection in order to ensure high quality data. 
 
 
EXPOSURE ASSESMENT 
 
Exposure is defined using a multifaceted approach. In particular, PM10 is 
assigned to each subjects following two approaches: (1) use of daily PM10 
concentration series from air quality monitors; (2) use of daily PM10 
concentration estimates  by the FARM model (the flexible air quality regional 
model), a three-dimensional Eulerian grid model for dispersion, transformation 
and deposition of particulates, capable to simulate PM10 concentration using a 
4 km–dispersion grid
.   
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1)Air Monitoring Stations 
We collected recordings of daily PM10 data by monitoring stations located at 
154 different sites throughout Lombardy, with three of them located in the city 
of Milan (“Verziere”, “Pascal-Città Studi” and “Senato”). We used daily 
concentration measured by single monitors in the study area to characterize 
PM10 exposure at the date of recruitment and until 365 days before, for each 
subject. Thus, we are able to estimate both short- and long-term exposure to 
the pollutant investigated.  As air monitoring station recordings for the area of 
interest are available from 2001, older exposures might also be estimated.  
We geocoded monitoring stations and study subject addresses to assign the 
latter daily PM10 concentration from: (1) the monitor at the lower distance to 
home address, defined “subject’s residence”; (2) the nearest monitor to the 
Center for Obesity and Work (“Verziere”), defined “Policlinico”; (3) daily 
exposure for Milan created averaging the three available city monitors, defined 
as “average Milan”. 
We assume that the day of the visit subjects are exposed to levels of PM10 
measured by the “Policlinico” station, as the time elapsed in the Hospital to 
perform all the examinations (approximately five hours) is supposed to be 
sufficient to experience outcomes related to very short-term effect. About 57% 
of SPHERE subjects live in the city and an additional 28% work in Milan (even 
if they live outside the city), overall a 67% of subjects spent many hours a day 
in the city or travelling from workplace to residence. Thus, longer exposure 
effects are evaluated by both residential and Milan monitors using appropriate 
lag time from recruitment date, as sensitivity analysis. However, very high 
correlation was observed among the three sources of exposition (RPoliclinico vs 
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Average Milan=0.99; RSubjects’ Residence vs Average Milan=0.94; RPoliclinico vs Subjects’ 
Residence=0.99). 
 
2)FARM Eulerian Model 
Estimated daily average concentrations of PM10 for the years 2007-2013 
based on the FARM Eulerian model were obtained from ARPA Lombardy. The 
FARM Eulerian model  is a Chemical Transport Models (CTM)  able to treat 
the main processes of chemical and physical nature of formation and removal 
of pollutants, in addition to the transport and dispersion by the action of wind 
and atmospheric mixing. By this model the Lombardy region was divided into a 
grid of 1678 cells (4x4 km), each associated with daily PM10 concentration 
estimates. Hence each subject was attributed: (1) the estimated daily 
exposure of the cell containing their residential address; (2) the exposure of 
the cell containing the address of the Center for Obesity and Work; (3) the 
daily average exposure for Milan, calculated as the average of the 22 cells that 
falls into the city boundaries. 
Eulerian model requires, as input data, emissions from area and point sources 
from emissions inventory (anthropogenic-mobile, industrial, commercial, 
domestic, rural sources); meteorology (wind, air temperature, pressure, 
relative humidity, cloud cover and height, precipitation, turbulent horizontal and 
vertical diffusivities, surface resistances and gas deposition velocities) and 
topography. Data elaborated by modeling systems integrates the ones of the 
monitoring network and allow to know air quality state on an extensive way on 
the territory. Thus, the advantage of Eulerian dispersion modeling, on 
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monitors, is that it allows to assess the population's risk  of exposure to air 
pollution in regions where there are no direct observations. Data estimated 
from the models are available until 2012, since the data validation imply a lag 
time of nearly 6 months and will soon be available for further data analysis.  
Considerations to keep in mind when comparing modelled and measured 
pollutants, are that models estimated mean concentration of a cell (16 Km), 
while monitors gave a punctual value which reflects the characteristics around 
the site and of the emissions sources. 
PM10 levels follows a seasonal trend. Critic periods are concentrated in 
autumn and winter seasons, which are characterized by atmospheric stability, 
calm wind and absence of precipitations. PM10 air concentrations depends, 
besides emissions, on  weather conditions during the days, in particular by 
rainfall, atmospheric stability  and wind.  
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WORKFLOW PROCESS 
                                                   
                                                  EVs isolation 
 
         
 
 
 
EXTRACELLULAR VESICLES ISOLATION 
 
Peripheral blood is collected in two EDTA tubes. We collect plasma fraction by 
centrifuging 2500 rpm for 15 minutes at room temperature. After centrifugation 
the intermediate stage (buffy coat), consisting 
mainly of lymphocytes and monocytes, was 
isolated and frozen. The EVs are then purified 
from plasma.  
Plasma is centrifuged three times at 1000 x g, 
2000 x g and 3000 x g for 15 minutes at 4°C, 
discarding the pellet to clean the cell debris.  
Microvesicles resuspension  
Incubation with a fluorescent   
staining dye (CFSE)  
antibody labelling 
MVs characterization 
miRNAs extraction  
miRNAs reverse transcription 
miRNAs preAmplification 
miRNAs analysis 
Figure 7. BeckmanCoulter 
Optima-MAX-XP 
Figure 6. Workflow process in the two phases of the project. 
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Figure 7. MACSQuant Analyzers 
The vesicles are then concentrated by ultracentrifugation (BeckmanCoulter 
Optima-MAX-XP) (Figure 7) at 110,000× g for 75min at 4°C.  
 
EVs IMMUNOPHENOTYPING BY FLOW CYTOMETRY 
 
The flow cytometry is a technique that allows the quantification and 
characterization of particles of biological origin due to their interaction with 
specific laser.  
Over the years it has emerged as a technique for the evaluation of the cells, 
while today it is also widely used to determine the size, morphology and origin 
of extracellular vesicles [39].  
The flow cytometry offers 
several advantages such as the 
possibility of multiparametric 
analysis, rapid analysis time 
(more than 1000 events / sec), 
reproducibility and statistical 
reliability of the measures.  
For our study we used the 
MACSQuant Analyzers (Miltenyi 
Biotech) (Figure 8), 
with two lasers scatter (FSC, SSC) and eight channels for fluorescence.  
The cells passage through the laser gives rise to a signal that is picked up by 
the sensor that collects light from the Forward scatter (FSC), giving 
Figure 8.MACSQuant Analyzers-Miltenyi 
Biotech 
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information on the vesicular volume, and a further signal that is picked up by 
the side scatter (SSC) at 90 degrees, which provides information on the 
density / granularity of the vesicles.  
In addition to these physical parameters has been possible to estimate 
biological parameters also thanks to 
the use of molecules / antibodies 
conjugated to fluorochromes that emit 
fluorescence at different wavelengths.  
FITC-carboxyfluorescein succinimidyl 
ester (CFSE) was used to 
discriminate the integrity of the 
vesicles, as it is a vital dye, non-
fluorescent molecule, capable of 
entering the cytoplasm of MVs, where 
intracellular esterases remove the 
acetate group and convert the 
molecule in the ester fluorescent. 
It is chosen, furthermore, to evaluate the presence of five subpopulations of 
microvesicles for each subject, through immunophenotyping with monoclonal 
antibodies capable of recognizing an epitope of a specific antigen (Figure 9). 
We use antibody (Ab) CD61-APC to recognize MVs from platelets[96]; CD66-
APC for MVs neutrophils; CD14-APC for MVs from monocytes[97]; CD105-
APC for MVs by endothelium; EpCAM-APC for MVs epithelium[98].  
Figure 9. MACSQuant Analyzers  operating  
principles 
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We  mark 350 µL of sample, resuspended with PBS three times filtered 0.10 
µM, with 7μL of Carboxy Fluorescein Siccinimidyl Ester (CFSE) to reach a final 
solution concentration of 0.02 µM.  
The samples are incubated at 37 ° for 20 minutes in the dark, to allow the 
activation of the fluorescent ester.  
The samples labeled with CFSE are dispensed in 5 tubes each containing 
respectively 6μL of one of the previously selected Abs: CD14, CD105, 
EpCAM, CD66 and CD61. Subsequently, the samples labeled with CFSE and 
antibody, are incubated for 20 minutes in the dark at 4 ° C to allow the 
activation of the Allophycocyanin(APC), the fluorophore conjugated to the 
antibody.  
Before use, each antibody is centrifuged at 17000 g for 30 minutes at 4 ° C to 
eliminate the presence of aggregates.  
We acquire 30 µL of sample double-labeled for multiparametric analysis by 
flow cytometry and the data obtained have allowed us to determine the 
concentration of intact double-positive microvesicles (CFSE +, APC +) and 
belonging to one of the five selected subpopulations.  
In addition, before the analysis, it is estimated the output signal from PBS 
triple filtered unmarked, which was used for the suspension of microvesicles,  
to remove the background / noise of the buffer and make sure that it doesn’t 
influence the analysis of samples and overestimate the concentration.  
The main limitation of the analysis is the small size and heterogeneity of the 
vesicles, between 0.1 and 1 micron, and the ability of the instrument in their 
detection.  
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For the vesicles, which have small dimensions when compared with the 
wavelength of the laser, is important a high sensitivity for both FSC and SSC . 
The scatter depends on the diameter, refractive index, absorption, and 
morphology of the vesicles, as well as by the wavelength of the laser.  
Generally, the vesicles are considered smooth spheres without absorption and 
it allows to determine their diameter knowing the wavelength of the laser and 
the refractive index. The limit is the the fact that the vesicles have a small 
range of refractive indices, between 1:36 and 1:40, for a wide range of sizes, 
from 190 to 1040 nm, and this makes it difficult to accurately assess their 
diameter. 
This limit has been mostly superseded by the new flow cytometers, as 
MACSQuant analyzer, which have a scatter SSC able to discriminate with high 
accuracy vesicles between 160-220 nm.  
We also improve the efficiency of the instrument with a double staining of MVs 
through markers fluorochrome-conjugated. To calibrate the instrument we use 
Fluoresbrite® Carboxylate Size Range Kit I, a mixture of polystyrene 
fluorescent microspheres with a size of 0.10μm, 0.20μm, 0.50μm, 0.75μm and 
1.0μm. 
To eliminate any kind of interference during the analyzes, the running buffer 
(containing a low concentration of salts), used to optimize the acquisition of 
the vesicles by the MACSQuant Analyzers, was filtered through a Millipore 
membrane 0.10 mM, to avoid the possible impurities present in the mixture.  
The cytometer shows us the results of the acquisition through cytograms.  
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Then we use FlowJo software for the analysis of these graphs, and to evaluate 
the characteristics of the vesicles. It allows us to organize and analyze 
samples, thus simplifying the statistical analysis and the creation of the gate 
for experiments with many samples, parameters and operations. 
Figure 10 shows an example of cytograms in which we report the gating that 
identifies the MVs intact (CFSE+) and among these, the MVs positive to the 
antibody (eg CD61+). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Cytograms of a MVs population, intact MVs and MVs positive to Ab CD61. 
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Figure 11. NanoSight LM10-HS 
EVs COUNT AND SIZE 
 
Nanoparticle Tracking Analysis (NTA) is a new method of analysis that can 
determine size and count of nano-particles suspended in a liquid. Thanks to 
an optical microscope with a red laser of 635 nm, 
it analyzes the Brawnian motion of vesicles 
suspended in a fluid and displays them in real time 
through a CCD camera with high sensitivity 
(Figure 11).  
The software is capable to display each particle 
and identify its center and position during the 
acquisition time. The image analysis allows to 
calculate the average of the distance between the positions of each particle in 
motion along the axes x and y. Using the Stokes-Einstein equation we get 
diffusion coefficient (Δt) and consequently the diameter (d) of each nano-
vesicle, knowing temperature (T) and viscosity (η) of the liquid: Dt = KB T3 πηd 
KB is the boltzmann constant. 
Various studies have suggested that NTA is able to improve the capabilities of 
flow cytometry to analyze exosomes and microvesicles because it is possible 
to detect more vesicles in the range size between 35 and 251 nm using NTA 
in comparison to flow cytometry[99].  
The accuracy of the calculation of the particle size by the software depends on 
several variables including the intrinsic characteristics of the particles, as the 
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Figure 12. NTA operating principles 
index of refraction.  
For particles with a high refractive index, for example gold and silver in 
aqueous systems, we can get accurate dimensions up to 10 nm; for particles 
with a lower refractive index, such as those of biological origin, the smallest 
size well analyzable is between 25 and 35 nm.  
However, the major limitation of the system is when the Brownian motion is so 
low that it does not allow to identify and track the 
center of the particle and its movements. This is 
typically observed for particles about 1-2μm in 
aqueous systems.  
To optimize the analysis is often necessary to 
dilute the sample to allow the instrument to view  
the most of all the particles. 
For our analysis were used 70 µL of the sample  
to which were added 230 µL of PBS three 
times filtered, to obtain a dilution of 4,28 : 1.  
The sample is transferred, using a syringe, into a chamber of NanoSight 
LM10-HS (ultrahigh sensitive) and we make five different video captures 
(Figure 12).  
Thanks to EMCCD camera (Electron Multiplication Charge Coupled Device), 
which has a higher sensitivity compared to the standard Nanosigh system, are 
recorded five movies of 30 seconds each to improve the statistical power of 
the analysis.  The NanoSight analysis helps to overcome the limitations due to 
flow cytometry in the size estimation of vesicles. 
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miRNAs EXTRACTION  
 
miRNAs analysis and quantification requires a previous miRNAs extraction 
and purification phase. For this purpose we use miRNeasy Kit and RNeasy 
CleanUp Kit (Qiagen) 
 
Procedure: 
1. Add 700 μl of  QIAzol Lysis Reagent in each sample 
2. Mix with pipette and transfer in a 2 ml tube 
3. Vortex for 1 min 
4. Place the tube at room temperature for 5 min 
5. Add 140 μl di chloroform and shake the tube vigorously for 15 s 
6. Place the tube at room temp for 2-3 min 
7. Centrifuge x 15 min at 12000 g at 8 °C.  
8. Transfer the upper aqueous phase to a new collection tube 
9. Add 350 μl of 70% ethanol 
10. Vortex  
11. Transfer 700 μl in a RNeasy spin column in a collection tube da 2 ml  
12. Centrifuge at ≥10200 rpm for 15 s at 20°C 
13. Trasfer the sample in a 2 ml tube(containing miRNA) 
14. Throw spin column (except if you want to extract also totalRNA) 
15. Add 450 μl of 100% ethanol and vortex 
16. Transfer 700 μl of sample in a RNeasy MinElute spin column in a 
collection tube  
17. Centrifuge for 15 s at ≥ 10200 rpm at 20°C 
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18. Transfer the spin column in a new collection tube 
19. Transfer the remainder of the sample in the RNeasy MinElute spin 
column and repeat the centrifuge 
20. Transfer in a new collection tube 
21. Add 500 μl of RPE Buffer in the RNeasy MinElute spin column and 
centrifuge for 15 sec at   ≥ 10200 rpm 
22. Transfer in a new collection tube 
23. Add 500 μl of 80 % ethanol and centrifuge x 2 min at ≥ 10200 rpm 
24. Transfer the spin column in a new collection tube 
25. Centrifuge with open lid for 5 min at ≥ 10200 rpm 
26. Transfer spin column in a 1,5 ml tube and add 20 μl of RNeasy free 
water 
27. Wait for 5 min 
28. Centrifuge x 1 min at  ≥ 10200 rpm 
29. Store at -80°C 
 
 
 
 
 
 
 
51 
 
miRNAs REVERSE TRANSCRIPTION 
 
Reverse Transcription (RT) allows to produce cDNA starting from RNA and for 
this reason is exploited to study gene expression. For the analysis of miRNAs 
carried in plasma vesicles, we used 2 mix for each sample: one containing 
Megaplex RT primers Pool A v2.1 and the other one with  Megaplex RT 
primers Pool B v3.0.  
For miRNAs are used RT specific primers, called "stem-loop RT primers" , 
which contain a highly stable loop structure that extends the target cDNA 
(miRNA are too short for standard methods of RT-qPCR).  
The Forward primer  increases the length by adding additional nucleotides that 
optimize its melting temperature (Tm) and improve the test specificity. The 
Reverse primer destroys the loop structure. Furthermore, the steric hindrance 
due to the presence of the loop structure prevents primer binding to pri- or pre-
miRNAs  that may be present. Each RT reaction mix contains (Table 4): 
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We aliquot 4,15μL of the RT reaction mix to each well of a 96-well plate (each 
sample is processed in two wells: one for pool A and one for pool B).  
Then we add 3.35 μL of RNA in each well containing the RT reaction mix and 
after we perform PCR reaction at the following conditions (Table 5): 
 
 
RT Reaction Mix 
component 
Volume 
 
MegaplexTM RT Primers 
(10X) (Pool A/Pool B) 0.75 μL 
-Pool A: RT primers for 377 miRNAs and 4 control miRNAs 
(miRNAs best characterized and most expressed ); 
-Pool B: RT primers for 377 miRNAs and 4 control miRNAs 
(miRNAs less characterized and / or expressed then Pool A ). 
dNTPS with dTTP 
(100mM) 0.15 μL  
MultiScribe Reverse 
Transcriptase (50U/μL) 1.50 μL 
It 'a DNA-dependent RNA polymerase (reverse transcriptase), 
derived from Moloney Murine Leukemia Virus, which uses 
ssRNA as a template to synthesize one strand of 
complementary DNA (cDNA) 
10X RT Buffer 0.75 μL Buffer to maintain the pH stable; is required to establish the 
environment for the reaction. 
MgCl2 (25Mm) 0.90 μL 
It is used to add magnesium ions to the PCR reaction.  
Magnesium is a cofactor of the polymerase and its 
concentration affects its productivity. 
RNase Inhibitor (20U/ μL) 0.1 μL RNase inhibitor 
Total 3.4 μL 
   Table 4. Components of RT reaction mix 
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REAL TIME-PCR  
 
The product of the preamplification reaction was diluted 1/20. The Real Time 
PCR reaction was prepared with "TaqMan Open Array Real Time PCR 
MasterMix". 
We transferred the reaction product (7μl), using a Robot Let Microlab STAR 
(Hamilton Robotics) from the plate 96 to 384. Finally through the AccuFillTM 
Robot System (Life Technologies) we set up the Open Array Plate consists of 
48 subarrays with 64 holes, for a total of 3072 holes of diameter 300 µM and 
300 µM of depth (Figure 13). 
 
Stage Temp Time 
Hold 95 °C 10 min 
Hold 55 °C 2 min 
Hold 72 °C 2 min 
Cycle 
(16 Cycles) 
95 °C 15 sec 
60 °C 4 min 
Hold* 99.9 °C 10 min 
Hold 4 °C ∞ 
Table 5. PCR conditions 
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Each hole has an outer hydrophobic coating, while inside is hydrophilic (the 
reagents are kept inside by surface tension) . In this way each reaction of real 
time PCR has a final volume of 33 nanoliters.  
After loading the sample, we covered the plate with adhesive Lid and filled 
with immersion fluid. The plate is loaded into 
QuantStudioTM 12K FlexOpenArray (Life 
Technologies) (Figure 14) that allows the 
simultaneous analysis of up to 4 
OpenArrayplates, for a total of 12 samples 
(3 per plate).  
The Real-Time PCR, also called 
quantitative PCR or real-time quantitative 
PCR (RTQ-PCR), is a method of amplification (polymerase chain reaction or 
PCR) and simultaneous quantification of DNA samples and cDNA.  
The fluorescence, generated during PCR, is the result of several possible 
chemical reactions.  
Figure 13.OpenArray plate 
Figure 14.QuantStudioTM 12K 
FlexOpenArray 
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The main chemistries are based on the binding of fluorescent dyes that 
intercalate into the double helix of DNA, such as SYBR Green, or on the 
hybridization of specific probes, such as TaqMan probes. In this experiment, 
we used the TaqMan probes. The use of probes revealing fluorescence is one 
of the most accurate and reliable methods, as the TaqMan probes are 
designed to pair up to specific target sequences. 
A typical cycle of real-time PCR 
1. Denaturation of template DNA (94-99°C).  
2. Annealing of the oligonucleotides to the sequence (30-65°C).  
3. Extension by DNA polymerase starting from the heat-resistant primers 
(65-72°C).  
The Real-Time PCR is quantitative, as the data are collected during the 
exponential growth phase, when the quantity of the reaction product is directly 
proportional to the initial amount of nucleic acid.  
The quantification of the miRNA is based on the fluorescence detected at each 
reaction cycle: at each cycle, the cDNA molecules are doubled, up to reach a 
plateau when the reagents are exhausted and the enzyme activity decreases 
drastically. 
The instrument software provides data analysis of the results:  
1) Relative TresholdCycle (Crt) (Figure 15): represents the number of PCR 
cycles at which the efficiency of the reaction of Real-Time PCR miRNA target 
is maximal. This data is used to quantify the initial target miRNA. The higher 
the Crt, the lower the expression of miRNAs.  
56 
 
2) Ampscore: one of the most important parameters that we used to evaluate 
the goodness of the reaction. A good amplifier has an Ampscore greater than 
1.24. This means that the curve representing its amplification, as a result of 
the Real-Time PCR, has the characteristic of an exponential growth curve. 
With this information, determine the ampscore can also help to discriminate 
false positives and false negatives. 
Unlike the Ct method, which considers all the curves for a specific target to 
determine the threshold, the Crt method sets a threshold for each curve 
individually that is based on the shape of the amplification curve,  regardless 
of the height or variability of the curve in its  early baseline fluorescence. The 
method first estimates a curve that models the reaction efficiency from the  
amplification curve. It then uses this curve to determine  the relative threshold 
cycle (Crt) from the amplification curve. The Crt algorithm computes a Cq that 
is roughly in the middle of the exponential growth region.  
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The analysis of the results was carried out with the program Expression Suite.  
We have selected the reactions up to the 28th cycle of RTq-PCR, as 
hypothetical amplifications occurred in subsequent cycles are irrelevant for the 
study. 
 
 
 
 
 
                                                       
Figure 15: Relative Treshold Cycle (Crt) 
58 
 
RESULTS 
 
STUDY SUBjECT CHARACTERISTICS 
 
The population examined in this study includes 1250 subjects recruited at 31 
December 2013, 87% of whom living in the province of Milan. In particular we 
recruited 883 subjects for miRNAs study (recruited from 2010 till 2012) and 
266 (recruited from January till November 2013) subjects for MVs 
characterization. 
We structured the study in two phases to better investigate both the cellular 
origin of microvesicles both their content in terms of miRNAs. 
The characteristics of the study population in the two different phases of this 
study (miRNAs analysis and MV characterization) are similar and reflect those 
of the entire population (Table 6 and Table 7). 
The study population is recruited  at the Center for Obesity and Work (IRCCS 
Fondazione Ca’Granda Ospedale Maggiore Policlinico). The participation rate 
was 90%. Mean BMI of our study population is 33.5 Kg/cm2 (±5.5): nearly 
27.8% are overweight, 38.6% are obese, and 33.6% severe obese. 
The percentage of obese individuals in Lombardy is about 10.3% of the total 
adult population. The condition of overweight/obesity in Italy increases with 
age, is more common in men and among people with lower education and 
most economically disadvantaged. (Fonte Rapporto sui fattori di rischio in “Noi 
Italia” di ISTAT)  
The study population is composed by 74% of female, mean aged 52 years.   
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Characteristics Categories n=1250 
Sex Male 330 (26.4%) 
 Female 920 (73.6%) 
   
Age Years (mean±SD) 51.9±13.6 
   
Education Primary school or less 105 (8.4%) 
 Secondary school 325 (26.0%) 
 High school 493 (39.4%) 
 University 188 (15.0%) 
 Others 87 (7.0%) 
 Missing 52 (4.2%) 
   
Occupation Employee 714 (57.1%) 
 Unemployed 102 (8.2%) 
 Pensioner 304 (24.3%) 
 Housewife 93 (7.4%) 
 Missing 37 (3.0%) 
   
Ethnicity White 1198(95.8%) 
 Black 11 (0.9%) 
 Asian 3 (0.3%) 
 South America 38 (3.0%) 
   
Year of enrollment 2010 129 (10.3%) 
 2011 419 (33.5%) 
 2012 385 (30.8%) 
 2013 317 (25.4%) 
   
Season of enrollment Winter 320 (25.6%) 
 Spring 313 (25.0%) 
 Summer 190 (15.2%) 
 Autumn 427 (34.2%) 
   
Smoking Never 599 (47.9%) 
 Former 431 (34.5%) 
 Current 190 (15.2%) 
 Missing 30 (2.4%) 
   
Cigarettes smoked* <= 5  53 (27.9%) 
  5-10 53 (27.9%) 
  10-15 33 (17.4%) 
  15-20 37 (19.6%) 
  20-40 13 (6.8%) 
 Missing 1 (0.5%) 
   
Time since quitting (n=419) Median [Q1, Q3] 13.1 [5.8-23.4] 
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Pack/years (n=1153) Median [Q1, Q3]  
Among current and former  14.5 [6.1-28.0] 
   Including nonsmokers   0 [0-13.5] 
   
Alcohol consumption  Yes 636 (50.9%) 
   
   
   
 No 518 (41.4%) 
 Missing 96 (7.7%) 
   
Residence area City 534 (42.7%) 
 Peripheral area 331 (26.5%) 
 Rural area 30 (2.4%) 
 Village/small city 206 (16.5%) 
 Missing 149 (11.9%) 
   
Living area Province of Milan (Excluding City of 379 (30.3%) 
    City of Milan 713 (57.0%) 
 Outside Milan 158 (12.7%) 
   
Work area Province of Milan (Excluding City of 94 (13.1%) 
    City of Milan 339 (47.5%) 
 Outside Milan 34 (4.8%) 
 Missing 247 (34.6%) 
   
Floor of residence Ground floor 223 (17.8%) 
 First floor 244 (19.5%) 
 Second floor 156 (12.5%) 
 Beyond second floor 471 (37.7%) 
 Missing 156 (12.5.%) 
   
Residence traffic exposure Mild 108 (8.7%) 
 Moderate 595 (47.6%) 
 Heavy 369 (29.5%) 
 Missing 178 (14.2%) 
 
 
 
 
 
 
 
Table 6. Characteristics of study participants and data collected from the self-reported 
questionnaire  
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Characteristics N 
 
 
 
 BMI, Kg/cm2 1247 33.5±5.5 
BMI categorical 
  
  <30 Kg/cm2 
 
347 (27.8%) 
  30-35 Kg/cm2 
 
483 (38.6%) 
  ≥35 Kg/cm2 
 
420 (33.6%) 
Waist circumference, cm 1237 101.3±13.1 
Blood pressure, mmHg 1247 
 
  Sistolic 
 
125.4±15.8 
  Diastolic 
 
78.5±9.5 
  Above 140/90 mmHg 
 
60 (4.8%) 
  Below 140/90 mmHg 
 
1190 (95.2%) 
Heart rate, bpm 1243 67.6±10.4 
Uric acid 1163 5.2±1.4 
Fibrinogen, mg/dl 1129 335±59 
C-reactive protein 1160 0.3 [0.1-0.5] 
Total cholesterol, mg/dl 1165 215.1±41 
  HDL 
 
59.2±15.5 
  LDL 
 
134.7±36.3 
Triglyceride 1164 107 [77-145.5] 
Serum creatinine, mg/dL 1165 0.8±0.3 
AST, U/I 1159 19 [16-23] 
ALT, U/I 1160 21 [16-30.5] 
Gamma-Glutamyltransferase, IU/L 1162 19 [13-30] 
Glucose 1155 92 [86-101] 
Homocysteine 1151 10.4 [8.6-12.7] 
TSH 1163 1.7 [1.2-2.5] 
Glycated hemoglobin, mmol/mol 1159 39 [36.6-43] 
Postprandial glycaemia, mg/dl 1162 99 [90-112] 
Insulin level 1158 12.3 [8.8-18] 
2-hour post glucose insulin level 1155 46.4 [27.6-73] 
Urinary pH  1144 5.6±0.7 
Emocrome 1156 
 
White blood cells 
 
6.8±1.7 
Red blood cells 
 
4.8±0.4 
Hemoglobin 
 
13.8±1.4 
Hematocrit 
 
40.7±3.4 
Mean Corpuscolar Volume 
 
85.1±6.4 
Platelets 
 
249.7±59 
   
 Table 7. Characteristics of the study subjects and mean levels of the clinical measure  
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COMPARISON BETWEEN FARM MODEL AND MONITORING STATION 
PM10 LEVELS. 
 
Air quality modeling and ambient measurements are two different ways to 
estimate actual ambient concentrations of pollutants in the atmosphere. Both 
modeling and measurements have some degree of uncertainty associated 
with their estimates. 
Figure 16 shows the distributions of daily mean PM10 concentrations of all 
monitors and of all grid cells with a monitor falling into their boundary. Darker 
area highlights winter months, characterized by major differences between the 
two methods of exposure assessment. 
The winter months (October to February) are those where there is a more 
obvious difference between the two methods of exposure assessment; for the 
rest of the year the distributions are similar. 
 
 
 
Figure 16.Daily mean PM10 concentrations of all monitors and of all grid cells with a 
monitor falling into their boundary. Darker area highlights winter months, characterized 
by major differences between the two methods of exposure assessment 
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The differences between the two methods are consistent with what reported 
by ARPA Lombardy in the Annual Assessment Of Air Quality Modeling for 
years 2009-2011. 
We can summarize as follows the pros e cons of using PM10 exposure from 
FARM model air and from monitoring stations: 
FARM model: 
 provides an estimate of PM10 for a grid of 1678 cells 4x4Km; 
 no missing values in PM10 series; 
 is not easy to obtain (formal request to ARPA Lombardy); 
 validation requires long times (7-8 mesi); 
 high complexity of the model and the variables that feed it; 
Monitoring Stations: 
 easy availability from the site ARPA air quality; 
 validation times from 3 to 6 months, but not validated series are also      
available; 
 provides a punctual PM10 measure by 81 air monitoring stations; 
 lengthy procedure of estimation of missing data that is not always 
possible when the number of missing is high. 
In conclusion, individual air pollution exposure assessment is determined 
using two sources of information: 
actual monitor measurements for each and every day starting from January 
1st, 1990 and a regional well validated modelling systems applied starting 
from 2007.  
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We decide to use FARM model data exposure for the analysis of the 
association between PM10 exposure and miRNAs expression.  
Instead for the analysis of the association between PM10 and MVs 
subpopulation we used mean PM10 concentrations measured by the three 
Monitoring Stations in the city of Milan, this was necessary due to the lack of 
data from the FARM Eulerian model. 
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ASSOCIATION BETWEEN PM10 , EVs AND MVs SUBPOPULATION 
 
To assess the association between PM10 exposure and microvesicles 
concentration we use a multivariate statistical model adjusted for sex, BMI, 
interaction between PM10 and BMI and apparent temperature.  
The apparent temperature was calculated using the Kalkstein and Valimont 
formula : 
Ta = -2653 + (0994 * T) + (0.0153 * Dew ^ 2) 
where T is the temperature in Celsius degrees and Dew is the dew point. 
The study subpopulation consists of 266 subjects recruited from January 2013 
till November 2013. 
In this phase of the study we are attributing to each subject the PM10 exposure 
estimated in the center of Milan area using the mean of PM10 values measured 
by the three ARPA monitoring station (via Pascal, via Verziere, via Senato) , 
the blood drawing day.  
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As shown in Table 8, there is a 6.6% increase in the concentration of MVs 
CD61 + (from platelets); 3.4% for MVs CD66 + (neutrophils); 3.9% MVs for 
CD105 + (endothelium); 7% for MVs CD14 + (monocytes); while there is no 
significant association for MVs EpCAM + (from pulmonary epithelium); where 
Δ represents (exp (β) -1)% and indicates the percentage increase of MVs 
concentration with an increase of 1 μg / m3 of PM10.  
Here the graphical results presented in terms of ln (MVs subpopulation) in 
relation to the mean value of PM10 in the city of Milan (Figure 17). 
 
 
 
Association between PM10 and EVs 
Microvesicles Δ % IC 95% P-value β SE 
MVs CD61+ 6,6 (1.7; 11.6) 0,008 0.0637 ±0.024 
MVs CD66+ 3,4 (0.3; 6.7) 0,033 0.0338 ±0.016 
MVs EPCAM+ 3 (-0.5; 6.5) 0,097 0.0292 ±0.017 
MVs CD105+ 3,9 (0.3; 7.6) 0,034 0.0389 ±0.018 
MVs CD14+ 7 (2.6; 11.5) 0,002 0.0675 ±0.021 
MVs total 2,8 (0.7; 5.0) 0,010 0.0279 ±0.011 
Exosomes total 1,1 (-3.2; 5.6) 0,626 0.0109 ±0.022 
Table 8. Association between PM10 exposure and microvesicles 
concentration adjusted for sex, BMI, interaction between PM10 and 
BMI and apparent temperature. 
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A B 
C D 
Figure 17. Association between the Milan mean daily exposure (averaging the three 
available city monitors) of PM10 and MVs CD14+ (Panel A), MVs CD105+ (Panel B), MVs 
CD66+ (Panel C), MVs CD61+ (Panel D).  Adjusted for sex, body mass index, interaction of 
BMI and PM10 and apparent temperature. 
 
β:0.034 
p:0.033 
β:0.068 
p:0.008 
β:0.039 
p:0.034 
β:0.064 
p:0.034 
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INTERACTION BETWEEN PM10 AND OBESITY 
 
The average value of PM10 (derived from the average of PM10 values 
measured by the three ARPA stations in the city of Milan, the blood drawing 
day) is 34.29 mg / m 3 (SD ± 16.7);  the minimum value is 9 g / m3; median 
31.5 g / m3 and maximum value 103 μg / m3.  
Scientific evidence attests the link between obesity and environmental 
pollution, stating that the obese individuals are more susceptible to PM10 
exposure, as discussed previously, so we test the interaction of the BMI 
values between PM10 exposure and microvesicles concentration.  
We observe an interaction between the PM10 and the BMI value of the 
different subjects (Figure 18). For each value of PM10 ,as the value increases 
in body mass index, we  observe an increase in microvesicles release for all 
the subpopulation analyzed, CD61+ (platelets), CD66+ (neutrophils), CD105+ 
(endothelium), CD14+ (monocytes) and EpCAM+ (lung epithelium); so, at the 
same PM10 concetration, the overweight subjects with BMI 24-30 have less 
microvesicles than obese with a BMI ≥ 30.  
This means that the association between PM10 and plasma microvesicles 
seems to be conditioned by body mass index. 
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Figure 18.Interaction between PM10 and BMI 
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ASSOCIATION BETWEEN miRNAs EXPRESSION AND PM10 EXPOSURE 
 
In order to verify the association between miRNAs expression and PM10 we 
first fitted multiple linear regression models. As exposure was considered the 
daily PM10 exposure estimate (μg/m3) from Eulerian model for the 4x4 km cell 
containing the address of the Center for Obesity and Weight Control. The 
exposure lag period chosen for the analysis is of zero days (daily exposure of 
blood collection day). As outcome was considered the Relative quantification 
RQ of each miRNAs. log2 transformation was applied in order to satisfy the 
normality assumption of linear regression model. False discovery rate control 
(FDR) was applied to control the expected proportion of incorrectly rejected 
null hypothesis in multiple comparisons (threshold of 0.10). The following 
adjusting variables were selected: sex, age, body mass index, cigarette 
smoking (never, former, or current). We also adjusted for seasonality (using 
sine and cosine) and apparent temperature. 
In Table 9 is shown the association between FARM model estimate of PM10 
daily exposure and miRNAs expression. Have been reported the first 52 
miRNAs, all statistically significant, because they are those that will be 
examined in a second phase of validation study in Real Time PCR on a further 
1000 subjects. In Figure 19 are shown the graphical results of the association 
between eulerian estimate of PM10 daily exposure and miR106a, miR152, 
miR218 expression (adjusted for age, sex, body mass index, cigarette 
smoking, date, Seasonality  and apparent temperature). 
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Estimate β StdErr LowerCL UpperCL Raw pvalues 
FDR 
pvalues 
miR-106a -0,01224 0,00241 -0,01697 -0,00751 0,00000 0,00000 
miR-152 -0,01315 0,00320 -0,01943 -0,00687 0,00000 0,00000 
miR-218 -0,01462 0,00351 -0,02150 -0,00774 0,00000 0,00000 
miR-27b -0,01655 0,00379 -0,02399 -0,00912 0,00000 0,00000 
miR-30d -0,01560 0,00354 -0,02254 -0,00866 0,00000 0,00000 
miR-652 -0,02350 0,00502 -0,03336 -0,01364 0,00000 0,00000 
miR-92a -0,01135 0,00276 -0,01677 -0,00594 0,00000 0,00000 
miR-181a-2 -0,01487 0,00387 -0,02246 -0,00728 0,00010 0,00351 
miR-25 -0,01225 0,00308 -0,01829 -0,00621 0,00010 0,00351 
miR-375 -0,01757 0,00437 -0,02614 -0,00900 0,00010 0,00351 
miR-720 -0,01085 0,00275 -0,01624 -0,00546 0,00010 0,00351 
miR-9 -0,01555 0,00387 -0,02314 -0,00796 0,00010 0,00351 
let-7c -0,01423 0,00379 -0,02167 -0,00678 0,00020 0,00479 
miR-1274B -0,01171 0,00309 -0,01778 -0,00564 0,00020 0,00479 
miR-24 -0,00921 0,00248 -0,01408 -0,00435 0,00020 0,00479 
miR-28 -0,01487 0,00397 -0,02267 -0,00707 0,00020 0,00479 
miR-99b -0,01209 0,00321 -0,01839 -0,00579 0,00020 0,00479 
let-7g -0,01264 0,00348 -0,01946 -0,00581 0,00030 0,00479 
miR-136 -0,01500 0,00411 -0,02306 -0,00693 0,00030 0,00479 
miR-18a -0,01275 0,00353 -0,01968 -0,00581 0,00030 0,00479 
miR-20a -0,01357 0,00375 -0,02093 -0,00620 0,00030 0,00479 
miR-27a -0,01276 0,00348 -0,01959 -0,00593 0,00030 0,00479 
miR-331 -0,01069 0,00292 -0,01642 -0,00497 0,00030 0,00479 
miR-744 -0,01352 0,00376 -0,02090 -0,00615 0,00030 0,00479 
miR-590-3P -0,01442 0,00414 -0,02255 -0,00628 0,00050 0,00712 
miR-20a -0,00969 0,00286 -0,01531 -0,00407 0,00070 0,00878 
miR-22 -0,01349 0,00398 -0,02130 -0,00568 0,00070 0,00878 
miR-423-5p -0,01235 0,00364 -0,01951 -0,00520 0,00070 0,00878 
let-7d -0,01584 0,00468 -0,02503 -0,00665 0,00080 0,00980 
miR-184 -0,01485 0,00444 -0,02356 -0,00614 0,00090 0,01054 
miR-766 -0,01148 0,00344 -0,01824 -0,00472 0,00090 0,01054 
miR-301b -0,01262 0,00381 -0,02010 -0,00515 0,00100 0,01146 
miR-340 -0,01264 0,00387 -0,02024 -0,00504 0,00110 0,01233 
miR-126 -0,01520 0,00469 -0,02440 -0,00599 0,00120 0,01291 
miR-185 -0,01022 0,00319 -0,01649 -0,00395 0,00140 0,01366 
miR-340 -0,01345 0,00420 -0,02168 -0,00521 0,00140 0,01366 
miR-625 -0,01705 0,00531 -0,02749 -0,00662 0,00140 0,01366 
miR-598 -0,01223 0,00383 -0,01974 -0,00471 0,00150 0,01405 
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miR-125b -0,01045 0,00329 -0,01692 -0,00399 0,00160 0,01405 
miR-127 -0,01450 0,00457 -0,02347 -0,00553 0,00160 0,01405 
miR-26b -0,00945 0,00298 -0,01531 -0,00360 0,00160 0,01405 
miR-505 -0,01185 0,00381 -0,01932 -0,00438 0,00190 0,01615 
miR-143 -0,01187 0,00382 -0,01937 -0,00437 0,00200 0,01652 
miR-148b -0,01331 0,00432 -0,02179 -0,00483 0,00210 0,01652 
miR-186 -0,01144 0,00370 -0,01870 -0,00417 0,00210 0,01652 
miR-642 -0,01275 0,00413 -0,02085 -0,00464 0,00210 0,01652 
miR-638 -0,01745 0,00568 -0,02859 -0,00631 0,00220 0,01680 
miR-148a -0,02181 0,00716 -0,03587 -0,00775 0,00240 0,01686 
miR-17 -0,00971 0,00318 -0,01596 -0,00346 0,00240 0,01686 
miR-223 -0,00661 0,00218 -0,01088 -0,00233 0,00250 0,01734 
miR-19b -0,00750 0,00248 -0,01237 -0,00262 0,00260 0,01757 
miR-224 -0,01370 0,00459 -0,02272 -0,00468 0,00290 0,01935 
Table 9. Association between FARM model estimate of PM10 daily exposure and miRNAs 
expression adjusted for age, sex, body mass index, cigarette smoking, date, seasonality (using 
sine and cosine) and apparent temperature. Only the first 52 miRNAs with FDR pValue < 0.1 
are shown. 
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Figure 19. Association between eulerian estimate of PM10 daily exposure and miR-106a 
(Panel A), miR-152 (Panel B),  miR-218 (Panel C) expression adjusted for age, sex, body 
mass index, cigarette smoking, date, Seasonality (using sine and cosine) and apparent 
temperature. 
A 
B 
C 
β:-0.012 
FDRp:0.00 
β:-0.013 
FDRp:0.00 
β:-0.015 
FDRp:0.00 
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MEDIATION ANALYSIS TO INVESTIGATE THE ROLE OF miRNAs 
EXPRESSION AS MEDIATOR OF THE EFFECT OF PM10 ON CARDIAC 
OUTCOMES:SYSTOLIC AND DIASTOLIC BLOOD PRESSURE. 
 
Mediation is a hypothesized causal chain in which one variable affects a 
second variable that, in turn, affects a third variable. The intervening variable, 
M, is the mediator. It “mediates” the relationship between a predictor, X, and 
an outcome. Graphically, mediation can be depicted in the following way: 
        a                   b 
X                 M                 Y 
Paths a and b are called direct effects. The mediational effect, in which X 
leads to Y through M, is called the indirect effect. The indirect effect represents 
the portion of the relationship between X and Y that is mediated by M. 
The hypothesis underlying this analysis is that miRNAs expression can acts as 
mediator effect of the total effect of the exposure variable PM10 on cardiac 
functions measured by respectively Systolic (Table 10) and Diastolic Blood 
Pressure (Table 11). 
                      
                        
M 
 miRNAs 
expression 
Y 
Dependent  
variable: BP 
X  
Independent 
Variable: 
PM10 
Figure 20. Simple mediation model 
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Figure 20 represents a simple mediation model where, a is the coefficient for X (PM10) 
in a model predicting the mediator M (miRNAs expression) from X, and b and c are 
the coefficients in a model predicting the Y (blood pressure) from both the mediator M 
and X, respectively. 
Is a four step approach in which several regression analyses are conducted and 
significance of the coefficients is examined at each step (Figure 21).                
 
 
 
If one or more of these relationships are non-significant, researchers usually 
conclude that mediation is not possible or likely.          
 
 
 
 
 
 
Figure  21. Causal steps approach 
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There are the conditions to state that miR106a expression explains SBP when 
controlling for PM10 and that the data are consistent with the hypothesis that 
miR106a expression fully mediates the relationship between PM10 and SBP. 
Finally, the Sobel tests is significant (p=0.015), indicating that the mediation 
pathway (operated by miR106a) is statistically significant. Moreover we can 
estimate that percent of the total effect that is mediated is about 36.8% and an 
indirect effect of 0.010.    
 
 
 
SystoliĐ Blood Pressure 
miRNAs IndireĐt EffeĐt  
Soďel 
test 
p-value 
Proportion 
Mediated    ;%Ϳ 
miR ϭϬϲa Ϭ.ϬϭϬ Ϭ.Ϭϰ ϯϲ.ϴϯ 
miR ϭϱϮ Ϭ.ϬϬϭ Ϭ.ϳϱϲ Ϯ.ϳϬ 
miR ϭϴϭa Ϭ.ϬϬϳ Ϭ.ϭϭϴ Ϯϱ.ϯϭ 
miR Ϯϭϴ -Ϭ.ϬϬϱ Ϭ.ϭϳϮ ϭϳ.ϵϰ 
miR Ϯϳď Ϭ.ϬϬϮ Ϭ.ϯϯϵ ϳ.ϮϮ 
miR ϯϬd Ϭ.ϬϬϮ Ϭ.ϰϴϯ ϴ.Ϭϴ 
miR ϲϱϮ Ϭ.ϬϬϯ Ϭ.ϯϴϵ ϭϭ.ϮϬ 
miR ϵϮa Ϭ.ϬϬϰ Ϭ.ϭϴϵ ϭϯ.ϱϬ 
miR Ϯϱ Ϭ.ϬϬϮ Ϭ.ϰϴϯ ϲ.Ϯϯ 
miR ϯϳϱ Ϭ.ϬϬϱ Ϭ.Ϯϯϭ ϭϳ.ϰϵ 
Table 10. Mediation analysis of the effect of exposure to PM10 on 
Systolic Blood Pressure (SBP) through miRNAs expression. 
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No miRNAs seems to act as mediator of the effect of PM10 on Diastolic Blood 
Pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DiastoliĐ Blood Pressure 
miRNAs IndireĐt EffeĐt  
Soďel 
test 
p-value 
Proportion 
Mediated    ;%Ϳ 
miR ϭϬϲa Ϭ.ϬϬϮ Ϭ.ϱϯϲ ϴ.ϴϵ 
miR ϭϱϮ Ϭ.ϬϬϭ Ϭ.ϲϳϲ Ϯ.ϴϯ 
miR ϭϴϭa Ϭ.ϬϬϯ Ϭ.Ϯϴϱ ϭϮ.ϴϲ 
miR Ϯϭϴ -Ϭ.ϬϬϮ Ϭ.ϯϯϬ ϵ.ϰϰ 
miR Ϯϳď Ϭ.ϬϬϮ Ϭ.ϮϯϬ ϳ.ϵϴ 
miR ϯϬd -Ϭ.ϬϬϭ Ϭ.ϱϵϳ ϰ.ϲϱ 
miR ϲϱϮ Ϭ.ϬϬϯ Ϭ.ϭϱϬ ϭϱ.ϯϮ 
miR ϵϮa -Ϭ.ϬϬϬϮ Ϭ.ϴϱϱ ϭ.ϮϮ 
miR Ϯϱ Ϭ.ϬϬϬϭ Ϭ.ϵϵ Ϭ.Ϭϰ 
miR ϯϳϱ Ϭ.ϬϬϮ Ϭ.ϰϳϲ ϳ.ϳϴ 
Table 11. Mediation analysis of the effect of exposure to PM10 on 
Diastolic Blood Pressure (DBP) through miRNAs expression. 
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PATHWAY ANALYSIS FOR THE CANDIDATE miRNAs 
 
The candidate miRNAs were subjected to pathway exploration using the 
Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Redwood City, 
CA) . 
Using this software, top-ranked pathways were also determined.  
Moreover are provided the biological functions associated with these miRNAs, 
such as the diseases in which they are involved (Figure 22). 
 
                 
                
 
 
 
 
Figure 22. Biological functions and diseases associated with candidate miRNAs 
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DISCUSSION 
 
 
The purpose of this study was to investigate the changes in extracellular 
vesicles induced by PM10 exposure both by observing changes in the number 
of specific subpopulations and quantifying the expression levels of miRNAs 
they contains. In the first part of the study, we analyzed the variation, in term 
of concentration, of plasma microvesicles in association with PM10 exposure. 
The choice of a population of overweight/obese individuals is justified by 
extensive scientific evidence that prove a link between obesity and air 
pollution; In fact, subjects with a greater body mass index seem to be more 
susceptible to the effect of acute inflammation triggered by exposure to PM10, 
probably due to a greater absorption of the metals contained in it [93, 100] . 
Hence, the obese population seems to represent a good population to 
investigate the effects of exposure to PM10 in clinical and molecular level, as 
the most sensitive but healthy population. 
In particular, for the study of MVs subpopulations, we decided to investigate 5 
subpopulations of MVs by flow cytometry: MVs from monocytes (CD14+), MVs 
from platelets (CD61+), MVs from neutrophils (CD66+), MVs from endothelium 
(CD105+), MVs from epithelium (EpCAM+). We performed multiparametric 
analysis, evaluating multiple characteristics of the MVs as the integrity and the 
tissue of origin, through the use of antibodies specific for antigens of surface. 
We focused on subpopulations of MVs involved in inflammation, coagulation 
and activation of pulmonary epithelial because we hypothesized that the 
increase of their concentration in plasma is associated with PM10 exposure. 
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We assumed that PM10 is able to establish a state of acute inflammation and 
damage at the level of the lung tissue and through the release of MVs can 
impact on the emergence of cardiovascular disease [101-103]. 
Plasma concentrations of MVs derived from platelets, monocytes, neutrophils 
and endothelial cells appear to be associated to PM10 exposure, while the 
association was not significant for the lung epithelium-derived MVs. This could 
prove our assumption that basicly is a cascade mechanisms of intercellular 
communication; starting by inflammation and activation of pulmonary 
epithelium, the MVs released could reach and activate the endothelial barrier 
and finally stimulate and determine the release of MVs by all hematopoietic 
cell types. For this reason they have not been found significant levels of MVs 
from lung epithelium in the plasma, as their major function would be performed 
at the interstitial level. 
The total concentration of microvesicles was analyzed by NTA, allowing to 
separate the microvesicles by exosomes. 
Microvesicles appear to be associated with exposure to PM10, while the total 
amount of exosomes is not significant. This highlights the difference between 
the two types of vesicles, therefore exosomes and microvesicles may have a 
different role in the mechanisms of communication both pathological and 
physiological. 
For miRNAs study, performed through TaqMan Open Array Real Time PCR, 
we test the association between PM10 exposure and the different levels of 
expression of 733 human miRNAs (with known and unknown biological 
function). 
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This phase of the SPHERE study had the aim of screening the entire 
miRNome on a population of approximately 1000 subjects (half of the total 
population). In a second step the 52 miRNAs results as more associated with 
the PM10 will be validated through standard Real Time- PCR on a population 
of comparable size. 
Therefore, the data shown represent a first survey to which must necessarily 
follow a validation phase on selected miRNAs. 
Finally, a standard approach was applied to perform mediation analysis in 
order to investigate the role of miRNAs expression as mediator of the effect of 
PM10 on cardiac outcome: Systolic and Diastolic Blood Pressure. We applied 
Sobel test to test the null hypothesis that the ‘‘true’’ indirect effect is zero, with 
the p-value derived from the standard normal distribution. In particular, we can 
estimate that 36.8% of the effect of PM10 on Systolic Blood Pressure is 
mediated by miR-106a.  
Focusing on a preliminary analysis of miRNA-106a and through a literature 
review, has emerged an important role of this miRNA:   modulating 
hematopoietic lineage determination and formation, including 
monocytopoiesis[104, 105].  
Previous studies [106, 107] suggest that miR-106a (togheter with miR-17 and 
miR-20a) effectively regulate macrophage inflammatory responses through 
modulating leukocyte SIRPa synthesis. As an important signaling molecule, 
SIRPa modulates many aspects of leukocyte inflammatory responses, 
including activation, chemotaxis, and phagocytosis. miR-106a is involved in 
macrophage infiltration through the direct suppression of expression of signal-
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regulatory protein α (SIRP α). A downregulation of mir-106a seems to act in 
favor of the differentiation of monocytes into macrophages as we can see in 
the Figure 23.  
 
 
 
 
Macrophage infiltration occurs in many tissue types, such as adipose tissue, 
the vascular system, liver and muscle and it is involved in the processes of 
formation of atherosclerotic plaques. The resident macrophages in tissues and 
organs play critical roles in controlling physiological functions and systemic 
homeostasis in tissues. miRNAs are a set of potent regulators of macrophage 
differentiation, infiltration, activation and cell-cell interactions. 
Further investigations are required. In particular, after the validation phase will 
follow an investigation step using bioinformatics tools to clarify the role of 
identified miRNAs and their implications in biological processes and human 
diseases. 
Figure 23. MicroRNA regulation of monocytic maturation and macrophage polarization. 
Chang, R.C., et al., Cells, 2014. 3(3): p. 702-12. 
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Future directions in research activities will be also to evaluate other exposure 
models: we will perform personal air pollution measures of PM, using passive 
samplers, on a subgroup of 200 selected subjects, and additionally will also be 
used metals determination in urine and hair to estimate short/medium term 
exposure. 
The proposed research will help to shed light on the chain of events that from 
air pollution exposure leads to CVD trying to explore a new mechanism which 
involves alteration of extracellular vesicles production and content. Our 
findings, if confirmed, could lead to the identification of potentially-reversible 
alterations that might be also considered as potential target for new diagnostic 
and therapeutic interventions. 
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